Manufacturers told to CE-mark early for Europe's IVDD (In Vitro Diagnostics Directive) to beat the anticipated market scramble
This article was originally published in Clinica
There will be strong market pressure on manufacturers to CE-mark in vitro diagnostic tests early in the transition period of the In Vitro Diagnostics Directive (IVDD), delegates were told at the Advanstar Communications 2nd annual European in vitro diagnostic conference last week.
You may also be interested in...
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.
European Commission proposals for strengthening intellectual property protections in the EU, particularly the supplementary protection certificate (SPC) system, have been broadly welcomed by Europe’s brand industry. But the medical NGO, MSF, says the SPC proposals run counter to the commission’s own efforts to improve access to medicines.
Belgian developer of cancer diagnostics is building an infectious disease portfolio on the back of its new SARS-CoV-2 test and collaborations with Immunexpress and Endpoint Health.